The receptor that tames the innate immune response

Area of Science:

• Immunology
• Cell Biology
• Regenerative Medicine

Background:

• Tissue injury and hypoxia activate innate immune responses, increasing damage.
• Erythropoietin (EPO) is synthesized as a compensatory, anti-inflammatory, and anti-apoptotic response.
• The natural EPO response system is discoordinated, leading to significant tissue damage and sequelae.

Purpose of the Study:

• To investigate the EPO-mediated tissue-protective system.
• To understand the role of the tissue-protective receptor (TPR) in injury response.
• To explore therapeutic interventions for tissue injury by targeting the TPR.

Main Methods:

• Examined the temporal and spatial patterns of TPR expression post-injury.
• Characterized the EPO receptor involved in tissue protection, distinct from the hematopoietic receptor.
• Investigated novel molecules designed to selectively activate the TPR.

Main Results:

• TPR expression is upregulated by inflammation and hypoxia, appearing functionally after injury.
• EPO production is delayed, transient, and weak compared to early TPR expression.
• Novel EPO-mimicking molecules successfully substituted for deficient EPO in animal models, reducing injury.

Conclusions:

• The discoordinated EPO response presents a therapeutic window.
• Selective TPR activation offers a promising strategy to mitigate tissue damage.
• Targeting the TPR with exogenous ligands may treat various insults causing tissue injury and irreversible sequelae.